4553 — Towa Pharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- ¥129bn
- ¥323bn
- ¥228bn
- 62
- 81
- 54
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.16 | ||
| PEG Ratio (f) | 8.01 | ||
| EPS Growth (f) | 1.03% | ||
| Dividend Yield (f) | 2.54% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.76 | ||
| Price to Tang. Book | 1.06 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.51 | ||
| EV to EBITDA | 7.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.96% | ||
| Return on Equity | 12.13% | ||
| Operating Margin | 10.44% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 110,384 | 154,900 | 165,615 | 208,859 | 227,934 | 261,522 | 276,286 | 16.74% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -4.89 | +40.62 | -7.05 | -42.11 | +97.24 | -6.63 | +1.03 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Towa Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. It is a drug with the same effect, usage and dosage. The Company is involved in the sale and outsourced manufacture of products and generic drugs. The Company is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The Company is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
Directors
- Itsuro Yoshida PRE (68)
- Masao Tanaka CEX (67)
- Kazuhiko Konno SMD (66)
- Yasushi Naito SEO (57)
- Yusuke Amano SEO
- Norikazu Inoue SEO
- Takayuki Kanno SEO
- Shigehiro Kubo SEO
- Sadayuki Morino SEO (67)
- Osamu UCHIKAWA SEO
- Masaji Morikawa DSL
- Shigeki Fujita EXO
- Muneyoshi Kaji EXO
- Shuichi Katsuki EXO
- Katsutoshi Kawamura EXO
- Shinya Kida EXO
- Toshikazu Kokubun EXO
- Mitsuhiro Matsumoto EXO
- Jun Matsuo EXO
- Yutaka Okuda EXO
- Kiyoto Onchi EXO
- Takeshi Sugiura EXO
- Koichi Tamura EXO
- Toshiyuki Tanaka EXO
- Tetsuo Yamashita EXO
- Toshio Shirakawa DRC (68)
- Norikazu Eiki IND (73)
- Kenryo Goto IND (63)
- Kaori Oishi IND (44)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 19th, 1957
- Public Since
- April 5th, 2004
- No. of Shareholders
- 6,508
- No. of Employees
- 4,588
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 49,227,097
- Address
- 2-11, Shimbashi-cho, KADOMA-SHI, 571-8580
- Web
- https://www.towayakuhin.co.jp/
- Phone
- +81 669009100
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 4553
Similar to 4553
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Towa Pharmaceutical Co share price?
As of Today at 23:44 UTC, shares in Towa Pharmaceutical Co are trading at ¥2,618. This share price information is delayed by 15 minutes.
How has the Towa Pharmaceutical Co share price performed this year?
Shares in Towa Pharmaceutical Co last closed at ¥2,618 and the price had moved by -5.69% over the past 365 days. In terms of relative price strength the Towa Pharmaceutical Co share price has underperformed the Nikkei 225 Index by -0.61% over the past year.
What are the analyst and broker recommendations for Towa Pharmaceutical Co?
The overall consensus recommendation for Towa Pharmaceutical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Towa Pharmaceutical Co dividend yield?
The Towa Pharmaceutical Co dividend yield is 2.29% based on the trailing twelve month period.
Does Towa Pharmaceutical Co pay a dividend?
Last year, Towa Pharmaceutical Co paid a total dividend of ¥60, and it currently has a trailing dividend yield of 2.29%.Looking ahead, the next dividend pay date is 2025-06-01.
When does Towa Pharmaceutical Co next pay dividends?
We do not have data on when Towa Pharmaceutical Co is to next pay dividends. The historic dividend yield on Towa Pharmaceutical Co shares is currently 2.29%.
How do I buy Towa Pharmaceutical Co shares?
To buy shares in Towa Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Towa Pharmaceutical Co?
As of the previous close price of ¥2,618, shares in Towa Pharmaceutical Co had a market capitalisation of ¥129bn.
Where are Towa Pharmaceutical Co shares listed?
Here are the trading details for Towa Pharmaceutical Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4553
What kind of share is Towa Pharmaceutical Co?
Based on an overall assessment of its quality, value and momentum Towa Pharmaceutical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Towa Pharmaceutical Co share price forecast for 2025?
The analyst consensus target price for shares in Towa Pharmaceutical Co is ¥3,848. That is 46.99% above the last closing price of ¥2,618.
Analysts covering Towa Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of ¥318 for the next financial year.
Find out moreWhat is the trend in the Towa Pharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Towa Pharmaceutical Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -7.34%.
As of the last closing price of ¥2,618, shares in Towa Pharmaceutical Co were trading -10.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Towa Pharmaceutical Co PE Ratio?
The Towa Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 8.16. The shares last closed at ¥2,618.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Towa Pharmaceutical Co?
Towa Pharmaceutical Co's management team is headed by:
- Itsuro Yoshida - PRE
- Masao Tanaka - CEX
- Kazuhiko Konno - SMD
- Yasushi Naito - SEO
- Yusuke Amano - SEO
- Norikazu Inoue - SEO
- Takayuki Kanno - SEO
- Shigehiro Kubo - SEO
- Sadayuki Morino - SEO
- Osamu UCHIKAWA - SEO
- Masaji Morikawa - DSL
- Shigeki Fujita - EXO
- Muneyoshi Kaji - EXO
- Shuichi Katsuki - EXO
- Katsutoshi Kawamura - EXO
- Shinya Kida - EXO
- Toshikazu Kokubun - EXO
- Mitsuhiro Matsumoto - EXO
- Jun Matsuo - EXO
- Yutaka Okuda - EXO
- Kiyoto Onchi - EXO
- Takeshi Sugiura - EXO
- Koichi Tamura - EXO
- Toshiyuki Tanaka - EXO
- Tetsuo Yamashita - EXO
- Toshio Shirakawa - DRC
- Norikazu Eiki - IND
- Kenryo Goto - IND
- Kaori Oishi - IND